Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to examine the effect of tipranavir combined with
ritonavir, medications for the treatment of HIV-infection, on buprenorphine/naloxone (BUP) in
people who have been receiving the same dose of buprenorphine/naloxone for at least 3 weeks
before study entry.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
Boehringer Ingelheim
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone Ritonavir Tipranavir